>>Signaling Pathways>> Neuroscience>> Pain Research>>N-Palmitoyl Glycine

N-Palmitoyl Glycine (Synonyms: NHexadecanoylGlycine, PalGly)

Catalog No.GC44456

N-팔미토일 글리신(N-팔미토일 글리신)은 감각 뉴런에서 칼슘 유입과 산화질소(NO) 생성의 조절자 역할을 하는 내인성 지질입니다.

Products are for research use only. Not for human use. We do not sell to patients.

N-Palmitoyl Glycine Chemical Structure

Cas No.: 2441-41-0

Size 가격 재고 수량
10mg
US$44.00
재고 있음
50mg
US$158.00
재고 있음
100mg
US$273.00
재고 있음
500mg
US$938.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The acyl amides are a family of endogenous lipids that act as potent modulators of pain and inflammation. The best characterized members of this family are the arachidonoyl amides, which includes N-arachidonoyl ethanolamide (AEA; anandamide). N-palmitoyl glycine (PalGly) contains an 18-carbon saturated fatty acid that is amide-linked to glycine and is structurally similar to the phospholipid-derived N-acyl ethanolamines. Endogenously produced in rat skin and spinal cord, PalGly is present in 100-fold greater amounts in skin and 3-fold greater in brain compared to AEA. Injection of 0.43 µg PalGly in rat hindpaw inhibits heat-induced firing of nociceptive neurons in rat dorsal horn. PalGly treatment induces transient calcium influx in native dorsal root ganglion (DRG) cells and in the PTX-sensitive, DRG-like cell line F-11 (EC50 = 5.5 µM).

리뷰

Review for N-Palmitoyl Glycine

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-Palmitoyl Glycine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.